Author

K. Dilger

Observed names: K DILGER, K Dilger, K. DILGER, Karin Dilger

Observed institutions: Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Universitäts-Herzzentrum Freiburg-Bad Krozingen, Dr Falk Pharma (Germany)

OpenAlex ID: A5112849560

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

2010 · Walter Reinisch, Sieglinde Angelberger, et al. · Gut · 171

Ursodeoxycholic acid — adverse effects and drug interactions

2003 · W. Hempfling, K. Dilger, et al. · Alimentary Pharmacology & Therapeutics · 126

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

2010 · W. Kruis, L. Jonaitis, et al. · Alimentary Pharmacology & Therapeutics · 78

Enzyme induction in the elderly: Effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone

2000 · K Dilger · Clinical Pharmacology & Therapeutics · 65

Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.

2006 · H Herfarth, C Tjaden, et al. · PubMed Central · 58

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence

2017 · W. Kruis, V. Kardalinos, et al. · Alimentary Pharmacology & Therapeutics · 51

Inhibition of Cytochrome P450 3A: Relevant Drug Interactions in Gastroenterology

2003 · A. Sagir, M. Schmitt, et al. · Digestion · 41

Influence of CYP3A4, CYP3A5, and ABCB1 Genotype and Expression on Budesonide Pharmacokinetics: A Possible Role of Intestinal CYP3A4 Expression

2008 · M Ufer, K Dilger, et al. · Clinical Pharmacology & Therapeutics · 26

Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease

2006 · K. DILGER, M. ALBERER, et al. · Alimentary Pharmacology & Therapeutics · 26

High variation of tioguanine absorption in patients with chronic active Crohn's disease

2003 · P. Deibert, K. Dilger, et al. · Alimentary Pharmacology & Therapeutics · 24

A clinical trial on absorption andN‐acetylation of oral and rectal mesalazine

2007 · K. Dilger, D. Trenk, et al. · European Journal of Clinical Investigation · 15

P048 a Clinical Trial on Absorption and N-acetylation of Oral and Rectal Mesalazine

2007 · K. Dilger, D. Trenk, et al. · Journal of Crohn s and Colitis Supplements

Pharmacokinetics and Pharmacodynamics of Oral Budesonide in Children With Crohn's Disease

2006 · M ALBERER, A BUSCH, et al. · Journal of Pediatric Gastroenterology and Nutrition

Einfluss von Ursodeoxycholsäure auf den Zytochrom-P450–3A-Metabolismus bei Patienten mit primär biliärer Zirrhose und Gesunden

2005 · A Denk, K Dilger, et al. · Zeitschrift für Gastroenterologie

Time Profile of ACE-Activity in Plasma Following I.V.-Bolus Dose or I.V.-Infusion of the ACE-Inhibitor Quinaprilat

1996 · D. Trenk, K. Dilger, et al. · Clinical Pharmacology & Therapeutics

Comparative evaluation of the time profile of ACE activity in plasma following intravenous bolus dose or intravenous infusion of the ACE inhibitor quinaprilat

1995 · Dietmar Trenk, K. Dilger, et al.

Works count: 16

Citation count: 681

H-index: 11

I10-index: 11